187 Immune checkpoint inhibitor (CPI) efficacy in gastrointestinal tumors with microsatellite-stable with high tumor mutational burden (MSS-TMB-H) compared to microsatellite instability-high (MSI-H)

• James Yu,
• Robin Park,
• Ruoyu Miao,
• Iman Imanirad,
• Jose Laborde,
• Todd Knepper,
• Christine Walko,
• Richard D Kim

Affiliations

James Yu

H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA

Robin Park

H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA

Ruoyu Miao

H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA

Iman Imanirad

H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA

Jose Laborde

H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA

Todd Knepper

H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA

Christine Walko

H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA

Richard D Kim

H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA